ADAPTIVE BIOTECHNOLOGIES Revenue, Growth & Competitor Profile

DBA ADAPTIVE

Company Profile & Annual Report for Adaptive Biotechnologies

Access the complete profile.

Adaptive Biotechnologies Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology 541714
Address	1551 Eastlake Ave E Suite 200 Seattle, WA 98102 adaptivebiotech.com

Note: Revenues for privately held companies are statistical evaluations.




Adaptive Biotechnologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Adaptive Biotechnologies Annual Revenue and Growth Rate

Adaptive Biotechnologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2021	Details in Premium Report
2020
2019
2018
2017

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Adaptive Biotechnologies's revenues are gauged from an analysis of company filings.

Investor Activity

Adaptive Biotechnologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 11, 2015	16	100%	$195 MM
Complete list of funding rounds and total amounts in the Company Report

Adaptive Biotechnologies's Income Statement (based on Industry Averages)

	$ Millions (Industry Average)
Adaptive Biotechnologies Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Adaptive Biotechnologies is developing and marketing. Adaptive Biotechnologies's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
T-DETECT Pharmaceutical, medial and veterinary preparations; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection	06/03/2022
T T-DETECT Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection	01/22/2021
T Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection	01/22/2021

See all trademarks and details in the Full Report.

Recession Risk

Determine whether Adaptive Biotechnologies grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Adaptive Biotechnologies is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Adaptive Biotechnologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adaptive Biotechnologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Fairmont, WV	100
OMNICARE	Annapolis Junction, MD	92
NETCRAKER TECHNOLOGY	Waltham, MA	85
INC RESEARCH	Raleigh, NC	58
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	53
FORCE ENGINEERING	Chandler, AZ	45
CEPHALON	Frazer, PA	41
LABCORP DRUG DEVELOPMENT	Burlington, NC	40
PRA INTERNATIONAL OPERATIONS	Raleigh, NC	33

Nearby Competitors

These companies are similar in business line and location to Adaptive Biotechnologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FRED HUTCHINSON CANCER RESEARCH CENTER	Seattle, WA	100
ADAPTIVE BIOTECHNOLOGIES	Seattle, WA	18
ALLEN INSTITUTE	Seattle, WA	10
BARDY DIAGNOSTICS	Seattle, WA	8
SANA BIOTECHNOLOGY	Seattle, WA	7
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	Seattle, WA	5

Future Competition: Adaptive Biotechnologies's Fastest Growing Competitors

These companies are in the same general field as Adaptive Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)